U.S. flag
        An official website of the United States government
          Here’s how you know

      Official websites use .gov
                A
                .gov
                website belongs to an official government organization in the United States.
          Secure .gov websites use HTTPS
                A lock
                  (
                  
                  )
                   or
                  https://
                   means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.Search
                Menu
    
                      Información en Español
                      Search NINDSSearch NINDS
            

            Main navigation
  

        
              Health Information
                                     Toggle Health Information Dropdown
                                Disorders
                Clinical Trials
                Patient & Caregiver Education
                Public Education
                Support Resources
                Funding
                                     Toggle Funding Dropdown
                                Find Funding Opportunities
                About Funding
                Preparing Your Application
                After You Submit
                Determining Your Funding Likelihood
                Manage Your Award
                NINDS Small Business Program
                Training & Career Development
                Current Research
                                     Toggle Current Research Dropdown
                                Coronavirus and NINDS
                Focus on Disorders
                Focus on Tools & Topics
                Research Funded by NINDS
                Research at NINDS
                Scientific Resources
                Trans-Agency Activities
                News & Events
                                     Toggle News & Events Dropdown
                                Events
                News
                Director's Messages
                About NINDS
                                     Toggle About NINDS Dropdown
                                Who We Are
                What We Do
                Job Opportunities 
 Home
                                Current Research
                        Focus on Disorders
                        Alzheimer's Disease and Related Dementias
SHARE: Focus On Lewy Body Dementia (LBD) Research
Image
              Close up of light blue neurone. Lewy Body Dementia banner image.


An estimated 1 million Americans have Lewy Body Dementia (LBD), which includes features such as progressive dementia plus varying combinations of fluctuating cognition, visual hallucinations, mood disorders, and autonomic dysfunction. Lewy body dementia is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. These deposits, called Lewy bodies, affect chemicals in the brain whose changes, in turn, can lead to problems with thinking, movement, behavior, and mood. Lewy body disease has been discovered to be a common cause for clinical dementia. It encompasses dementia with Lewy bodies (DBL) and Parkinson’s disease dementia (PDD). The generic term “Lewy body dementia” encompasses both entities. Diagnosing LBD can be challenging for a number of reasons. Early LBD symptoms are often confused with similar symptoms found in other brain diseases like Alzheimer’s.

The NINDS supports a number of projects covering all aspects of LBD research.  Some of our bigger initiatives are list here:

Biomarkers for the Lewy body dementias

The purpose of the Biomarkers for the Lewy body dementias****program is****to 1) expand the collection of clinical data and biological specimens in the NINDS Parkinson’s Disease Biomarkers Program (PDBP), a community research resource, to include data from patients with Lewy Body Dementias (including Dementia with Lewy Bodies and Parkinson's Disease with Dementia), and 2) to support hypothesis-driven clinical research to discover biomarkers that will improve the efficiency and outcome of Phase II clinical trials for the Lewy Body dementias and to provide an expansion of this existing research resource center for dissemination of information and access by the scientific community for further advancing research in this field.

Parkinson’s Disease Biomarkers Program

The  Parkinson's Disease Biomarkers Program (PDBP) brings together multiple stakeholders dedicated to research and discovery that will advance diagnostic and progression biomarkers for Parkinson's disease and Lewy body dementia. This stakeholder group includes basic and clinical researchers, healthcare professionals, NINDS program staff, information technology experts and most importantly, people with Parkinson's disease and their families and friends.

More than 1 million individuals****in the U.S. have LBD
	Characterized by Lewy bodies – clumps of alpha-synuclein protein – which are a pathological hallmark of Parkinson’s disease
	Problems with thinking, movement, behavior, and sleep

NIH Estimates of Funding for Various Research, Condition, and Disease Categories

Research/Disease Areas*
			FY 2019
			(Actual)
			FY 2020
			(Actual)
			FY 2021
			(Actual)
			FY 2022
			EstimatedLewy Body Dementia
			$66
			$84
			$93
			$96*Dollars in millions and rounded*To learn more about this NIH Investment, please visit the Categorical Spending site and enter "Lewy Body Dementia".*

Related Federal Programs

National Alzheimer’s Coordinating Center (NACC)

The NACC was established by the NIA/NIH in 1999 to facilitate collaborative research on Alzheimer's disease. Using data collected from the NIA-funded Alzheimer's Disease Centers (ADCs) across the United States, NACC has developed and maintains a large relational database of standardized clinical and neuropathological research data. In partnership with the Alzheimer's Disease Genetics Consortium (ADGC), the National Cell Repository for Alzheimer's Disease (NCRAD), and the NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS), NACC provides a valuable resource for both exploratory and explanatory Alzheimer's disease research.

**Vist Federal RePORTER to view LBD research accross the Federal Government**

Proceedings & Outcomes

LBD and the National Plan to Address Alzheimer’s Disease

On January 4, 2011, the National Alzheimer's Project Act (NAPA) was signed into law. The Act defines "Alzheimer's" as Alzheimer's disease and related dementias (AD/ADRD), which includes frontotemporal degeneration (FTD), Lewy body dementia (LBD), vascular contributions to cognitive impairment/dementia (VCID), and mixed etiology dementias (MED).

ADRD 2016 Summit Overview for LBD

The 2016 Alzheimer’s Disease-Related Dementias (ADRD) Summit was hosted by the National Institute of Neurological Disorders and Stroke (NINDS) in collaboration with the National Institute on Aging (NIA). The 2016 ADRD Summit was mandated by the National Plan to address Alzheimer’s Disease as a follow-up to the 2013 ADRD Summit. The Summit set research priorities for LBD research, including:

**Establish Longitudinal Diverse Cohorts with Common Measures, Culminating in Autopsy**

1. Initiate clinical trials for LBD in diverse populations using therapies that address symptoms that have the greatest impact on patient function and caregiver burden.

2. Create longitudinal clinical, biological, and imaging resources to improve detection and diagnosis of DLB at the pre-dementia or prodromal stage including high risk PD patients.

**Discover Disease Mechanisms Through Brain Mapping and Genetics**

3. Characterize nervous system changes in LBD cohorts that have come to autopsy to identify disease-specific underlying mechanisms to guide biomarker and therapeutic approaches.

4. Identify novel common and rare genetic variants, epigenetic changes, and environmental influences that impact the risk for and clinical features of LBD.

**Develop and Validate Biological and Imaging Biomarkers**

5. Develop and validate imaging approaches to enhance the differential diagnostic accuracy of LBD, detect latent and prodromal LBD, and monitor disease progression in natural history and treatment studies.

6. Develop biomarkers for pathologic changes, disease progression, and diagnosis. Incorporate markers for diagnosis of latent or prodromal disease and for monitoring therapeutic responsiveness.

**Model Disease Processes to Develop Potential Symptomatic and Disease Modifying Therapies**

7. Develop LBD animal, cellular, and in vitro models that recapitulate key features, including clinical pathophysiologic heterogeneity to identify mechanistic candidates for interventions.

8. Develop disease-modifying interventions for LBD based on discovering biomarkers, molecular targets, and genetic and environmental modifiers that enhance, delay or prevent the onset of disease.



Resources and Tools

Contacts

Debra Babcock, Ph.D.| Program Director, Systems and Cognitive Neurosciencedbabcock@ninds.nih.gov

Beth-Anne Sieber, Ph.D. | Program Director, Neurodegenerationsieberb@ninds.nih.gov

Funding Opportunities

Alzheimer's Disease and Related Dementias Funding Opportunities

News & Events

New and Upcoming Opportunities for Alzheimer’s Disease-Related Dementias (ADRD) Research in Fiscal Year 2019

A new culprit tangles with ApoE4 in Alzheimer’s disease

Designer compound may untangle damage leading to some dementias

ADRD Summit 2022

Alzheimer's Association International Conference

NAPA Council



Related Topics

Lewy Body Dementia Association: About LBD

Alzheimer's Association Dementia with Lewy Bodies Page

Lewy Body Dementia Current Research
  
    

    Coronavirus and NINDS
                                                              
                    
                                      COVID-19 News & Events
    
            Coronavirus and the Nervous System
    
            ResourcesFocus on Disorders
                                                              
                    
                                      Alzheimer's Disease and Related Dementias
                                                              
                    
                                      Frontotemporal Dementia (FTD)
    
            Lewy Body Dementia (LBD) Research
    
            Mixed-Etiology Dementias (MED) Research
    
            Vascular contributions to cognitive impairment and dementia (VCID)Amyotrophic Lateral Sclerosis
    
            Epilepsy Research
                                                              
                    
                                      Curing the Epilepsies: The Promise of Research
    
            Epilepsy Therapy Screening Program (ETSP)Pain Research
    
            Parkinson's Disease Research
                                                              
                    
                                      Parkinson's Disease: Challenges, Progress, and Promise
    
            Parkinson’s Disease Research Centers of ExcellenceSpinal Cord Injury Research
    
            Traumatic Brain Injury Research
                                                              
                    
                                      NIH Chronic Traumatic Encephalopathy Diagnosis ConferenceUndiagnosed Disease Network
        
  
              
    
            Focus on Tools & Topics
                                                              
                    
                                      Biomarkers Research
                                                              
                    
                                      Biomarker Program FAQs
    
            Myalgic Encephalomyelitis / Chronic Fatigue Syndrome Biospecimen Resource Access Committee (ME/CFS BRAC)Health Disparities Research
    
            Focus on the Neural Exposome
    
            Neural Engineering Research
    
            Neuroethics
    
            Stem Cell Research
        
  
              
    
            Research Funded by NINDS
                                                              
                    
                                      Clinical Research
                                                              
                    
                                      Office of Global Health and Health Disparities
                                                              
                    
                                      HERN Initiative
    
            U.S.-Japan Brain Research Cooperative Program (BRCP)NeuroNEXT
                                                              
                    
                                      NeuroNEXT Clinical SitesNeuroscience Research
                                                              
                    
                                      Fundamental Neuroscience ResearchTranslational Research
                                                              
                    
                                      Active Projects for Partnering
    
            CREATE Bio
                                                              
                    
                                      CREATE Bio Application Support Library
    
            CREATE Bio Contract Resources/Consultants
    
            CREATE Bio Guidance DocumentsDTR Staff Publications about Programs
    
            Innovation Grants to Nurture Initial Translational Efforts (IGNITE Program)
                                                              
                    
                                      IGNITE - Definitions for Key Terms
    
            IGNITE Milestone ExamplesONETOX: Neural Exposome and Toxicology Programs
                                                              
                    
                                      The Neural Exposome
    
            Chemical Threats
    
            Chemical SafetyTranslational Devices
                                                              
                    
                                      Device Frequently Asked Questions
    
            Human Open Research Neural Engineering Technologies (HORNET) initiative
    
            Milestones for Translational Device Cooperative AgreementsUltra-rare Gene-based Therapy (URGenT) Network
                                                              
                    
                                      Current URGenT Projects
    
            URGenT External Consultant Board (ECB) Members
    
            URGenT Project Consultants & ContractsResearch at NINDS
                                                              
                    
                                      Blue Ribbon Panel Review of NINDS Intramural Research Program
                                                              
                    
                                      Blue Ribbon Panel Highlights
    
            Blue Ribbon Panel Roster
    
            Charge to the Blue Ribbon Panel
    
            Executive Summary of the NINDS Blue Ribbon Panel ReviewScientific Resources
                                                              
                    
                                      Animal Models
    
            Cell/Tissue/DNA
    
            Clinical and Translational Resources
    
            Gene ExpressionTrans-Agency Activities
                                                              
                    
                                      CounterACT Program
                                                              
                    
                                      CounterACT Contract Core Resources
    
            CounterACT Publications
    
            CounterACT Scientific Research Contacts
    
            Current CounterACT Researchers & Projects
    
            FDA Guidance Documents
    
            NIH CounterACT Researcher Honors and AwardsICARE: Interagency Collaborative to Advance Research in Epilepsy
    
            Interagency Research Coordinating Committees
    
            NINDS' Role in the HEAL Initiative
                                                              
                    
                                      Early Phase Pain Investigation Clinical Network (EPPIC-Net)
    
            Pain Therapeutics Development Program
    
            Preclinical Screening Platform for Pain (PSPP)Office of Emergency Care Research
                                                              
                    
                                      OECR Funded Awards
    
            Research Involving an Exception from Informed ConsentRigor & Transparency
                                                              
                    
                                      Initiative to Improve Education in the Principles of Rigorous Research
    
            Rigor Champions and Opportunities
                                                              
                    
                                      NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Initiative
    
            Rigor IconsRigor and Transparency Resources

Did you find the content you were looking for?
  Yes, I did find the content I was looking for



No, I did not find the content I was looking forPlease rate how easy it was to navigate the NINDS website
  Very easy to navigate



Easy to navigate



Neutral



Difficult to navigate



Very difficult to navigateThank you for letting us know! Any other feedback?Submit

This site is protected by reCAPTCHA and the Google Privacy Policyand Terms of Serviceapply.

      Last reviewed on February 28, 2024
        Contact Us
  

        
              Contact NINDS
                Visitor Information
        Related Sites
  

        
              Site Map
                National Institutes of Health
                Department of Health & Human Services
                USA.gov
        Policies
  

        
              Accessibility
                Freedom of Information Act
                Linking Policy
                Privacy Statement
                Vulnerability Disclosure Policy
Follow NINDS On Social Media
          
          National Institutes of Health (NIH)
          9000 Rockville Pike, Bethesda, MD, 20892